ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $56,032 | -47.4% | 2,206 | -16.0% | 0.00% | -40.0% |
| Q4 2022 | $106,511 | +3.4% | 2,626 | -15.5% | 0.01% | -16.7% |
| Q3 2022 | $103,000 | -29.5% | 3,108 | -25.1% | 0.01% | -14.3% |
| Q2 2022 | $146,000 | -23.6% | 4,150 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $191,000 | -33.4% | 4,150 | -4.1% | 0.01% | -20.0% |
| Q4 2021 | $287,000 | -34.2% | 4,328 | -38.1% | 0.01% | -28.6% |
| Q3 2021 | $436,000 | -48.6% | 6,991 | -31.7% | 0.01% | -30.0% |
| Q2 2021 | $848,000 | +33.3% | 10,236 | +6.7% | 0.02% | +33.3% |
| Q1 2021 | $636,000 | -14.5% | 9,592 | -1.1% | 0.02% | -6.2% |
| Q4 2020 | $744,000 | +7.7% | 9,701 | -39.6% | 0.02% | +6.7% |
| Q3 2020 | $691,000 | -29.7% | 16,050 | -29.5% | 0.02% | -31.8% |
| Q2 2020 | $983,000 | +158.7% | 22,754 | +72.1% | 0.02% | +144.4% |
| Q1 2020 | $380,000 | -72.8% | 13,221 | -40.0% | 0.01% | -71.0% |
| Q4 2019 | $1,397,000 | +125.3% | 22,019 | 0.0% | 0.03% | +121.4% |
| Q3 2019 | $620,000 | – | 22,019 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |